To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital

INTRODUCTION: Vernal conjunctivitis comprises 0.5% of allergic eye diseases. The study is intended to collate the effectiveness of drugs by observing the reduction in signs and symptoms. OBJECTIVES: The objective of the study is to evaluate the effectiveness and safety of olopatadine 0.1% ophthalmic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sruthi, Vadlakonda, Reddy, Resu Neha, Sowmini, K., Grace, Nagur Sharone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092179/
https://www.ncbi.nlm.nih.gov/pubmed/33666188
http://dx.doi.org/10.4103/ijp.IJP_174_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092179/
https://www.ncbi.nlm.nih.gov/pubmed/33666188
http://dx.doi.org/10.4103/ijp.IJP_174_20

Ejemplares similares